XML 88 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders’ Equity (Deficit) (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 26, 2023
$ / shares
shares
Aug. 10, 2023
Apr. 01, 2023
shares
Feb. 27, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2023
₪ / shares
Shareholders’ Equity (Deficit) [Line Items]                
Ordinary Shares | shares 97,500   292,500 1,950,000        
Exercise price (in Dollars per share) $ 5         $ 1.83    
Ordinary Share over a period   5 years            
Option to purchase     45 days          
Convertible preferred shares | shares         1      
Ordinary shares | shares         7,211,280      
Reverse share split         5:1      
Ordinary shares | shares         5      
Nominal value per share (in New Shekels per share) | ₪ / shares               ₪ 0.01
Investment amount (in Dollars) | $         $ 3,657      
Ordinary shares | shares         1,142,856      
Conversion percentage         80.00%      
Changes in the fair value of the convertible advance investment (in Dollars) | $         $ (269)  
Price (in Dollars per share)         $ 4      
Deemed dividend (in Dollars) | $         $ 7      
Purchase shares | shares         19,000      
Exercise price (in Dollars per share)         $ 4 $ 3.3 $ 3.2  
Vesting period         36 months      
IPO [Member]                
Shareholders’ Equity (Deficit) [Line Items]                
Public offering price (in Dollars per share)       $ 4 $ 4      
Aggregate gross proceeds (in Dollars) | $       $ 7,800        
Exercise price (in Dollars per share)         $ 5.12      
Ordinary Share over a period 5 years              
Incremental cost (in Dollars) | $         $ 1,418      
Deferred offering costs (in Dollars) | $              
Nominal value per share (in New Shekels per share) | ₪ / shares               ₪ 0.05
Changes in the fair value of the convertible advance investment (in Dollars) | $         $ 269      
Minimum [Member]                
Shareholders’ Equity (Deficit) [Line Items]                
Exercise price (in Dollars per share)         $ 1.48   1.8  
Authorized shares | shares         22,000,000      
Exercise price (in Dollars per share)         $ 1.48      
Maximum [Member]                
Shareholders’ Equity (Deficit) [Line Items]                
Exercise price (in Dollars per share)         $ 4   $ 3.2  
Authorized shares | shares         222,000,000      
Exercise price (in Dollars per share)         $ 3.73      
Convertible Advance Investment [Member]                
Shareholders’ Equity (Deficit) [Line Items]                
Conversion price (in Dollars per share)         $ 3.2      
Subsequent Event [Member]                
Shareholders’ Equity (Deficit) [Line Items]                
Convertible preferred shares | shares         2